Product References
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
Angiogenesis
Szulcek R,Sanchez-Duffhues G,Rol N,Pan X,Tsonaka R,Dickhoff C,Yung LM,Manz XD,Kurakula K,Kiełbasa SM,Mei H,Timens W,Yu PB,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to show that the BMP9-induced aberrant EndMT in PAH pulmonary ECs is dependent on exacerbated pro-inflammatory signaling mediated through IL6.
Sun Nov 01 00:00:00 UTC 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
Angiogenesis
Szulcek R,Sanchez-Duffhues G,Rol N,Pan X,Tsonaka R,Dickhoff C,Yung LM,Manz XD,Kurakula K,Kiełbasa SM,Mei H,Timens W,Yu PB,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to show that the BMP9-induced aberrant EndMT in PAH pulmonary ECs is dependent on exacerbated pro-inflammatory signaling mediated through IL6.
Sun Nov 01 00:00:00 UTC 2020
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Cells
Happé C,Kurakula K,Sun XQ,da Silva Goncalves Bos D,Rol N,Guignabert C,Tu L,Schalij I,Wiesmeijer KC,Tura-Ceide O,Vonk Noordegraaf A,de Man FS,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to analyse the BMPR2 expression and activity in the lungs of rats with experimentally induced PAH and compared this to the BMPR2 expression and activity in the lungs of PAH patients.
Mon Jun 08 00:00:00 UTC 2020
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Cells
Happé C,Kurakula K,Sun XQ,da Silva Goncalves Bos D,Rol N,Guignabert C,Tu L,Schalij I,Wiesmeijer KC,Tura-Ceide O,Vonk Noordegraaf A,de Man FS,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to analyse the BMPR2 expression and activity in the lungs of rats with experimentally induced PAH and compared this to the BMPR2 expression and activity in the lungs of PAH patients.
Mon Jun 08 00:00:00 UTC 2020
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Cells
Happé C,Kurakula K,Sun XQ,da Silva Goncalves Bos D,Rol N,Guignabert C,Tu L,Schalij I,Wiesmeijer KC,Tura-Ceide O,Vonk Noordegraaf A,de Man FS,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to analyse the BMPR2 expression and activity in the lungs of rats with experimentally induced PAH and compared this to the BMPR2 expression and activity in the lungs of PAH patients.
Mon Jun 08 00:00:00 UTC 2020
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Cells
Happé C,Kurakula K,Sun XQ,da Silva Goncalves Bos D,Rol N,Guignabert C,Tu L,Schalij I,Wiesmeijer KC,Tura-Ceide O,Vonk Noordegraaf A,de Man FS,Bogaard HJ,Goumans MJ
MA5-15827 was used in Western Blotting to analyse the BMPR2 expression and activity in the lungs of rats with experimentally induced PAH and compared this to the BMPR2 expression and activity in the lungs of PAH patients.
Mon Jun 08 00:00:00 UTC 2020
BMPR2 promotes fatty acid oxidation and protects white adipocytes from cell death in mice.
Communications biology
Qian S,Pan J,Su Y,Tang Y,Wang Y,Zou Y,Zhao Y,Ma H,Zhang Y,Liu Y,Guo L,Tang QQ
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Western Blot
Wed Apr 29 00:00:00 UTC 2020
BMPR2 promotes fatty acid oxidation and protects white adipocytes from cell death in mice.
Communications biology
Qian S,Pan J,Su Y,Tang Y,Wang Y,Zou Y,Zhao Y,Ma H,Zhang Y,Liu Y,Guo L,Tang QQ
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Western Blot
Wed Apr 29 00:00:00 UTC 2020
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody.
BMC research notes
Gorrell RE,Totten MH,Schoerning LJ,Newby JB,Geyman LJ,Lawless WG,Hum JM,Lowery JW
MA5-15827 was used in Immunoprecipitation to identify and validate a bone morphogenic protein type 2receptor neutralising antibody.
Tue Jun 11 00:00:00 UTC 2019
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody.
BMC research notes
Gorrell RE,Totten MH,Schoerning LJ,Newby JB,Geyman LJ,Lawless WG,Hum JM,Lowery JW
MA5-15827 was used in Immunoprecipitation to identify and validate a bone morphogenic protein type 2receptor neutralising antibody.
Tue Jun 11 00:00:00 UTC 2019
The Wnt Signaling Pathway Is Differentially Expressed during the Bovine Herpesvirus 1 Latency-Reactivation Cycle: Evidence That Two Protein Kinases Associated with Neuronal Survival, Akt3 and BMPR2, Are Expressed at Higher Levels during Latency.
Journal of virology
Workman A,Zhu L,Keel BN,Smith TPL,Jones C
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Immunofluorescence
Sun Apr 01 00:00:00 UTC 2018
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Circulation
Perros F,Günther S,Ranchoux B,Godinas L,Antigny F,Chaumais MC,Dorfmüller P,Hautefort A,Raymond N,Savale L,Jaïs X,Girerd B,Cottin V,Sitbon O,Simonneau G,Humbert M,Montani D
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Western Blot
Tue Sep 01 00:00:00 UTC 2015
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Circulation
Perros F,Günther S,Ranchoux B,Godinas L,Antigny F,Chaumais MC,Dorfmüller P,Hautefort A,Raymond N,Savale L,Jaïs X,Girerd B,Cottin V,Sitbon O,Simonneau G,Humbert M,Montani D
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Western Blot
Tue Sep 01 00:00:00 UTC 2015
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Circulation
Perros F,Günther S,Ranchoux B,Godinas L,Antigny F,Chaumais MC,Dorfmüller P,Hautefort A,Raymond N,Savale L,Jaïs X,Girerd B,Cottin V,Sitbon O,Simonneau G,Humbert M,Montani D
Published figure using BMPR2 monoclonal antibody (Product # MA5-15827) in Western Blot
Tue Sep 01 00:00:00 UTC 2015
Endothelial-to-mesenchymal transition in pulmonary hypertension.
Circulation
Ranchoux B,Antigny F,Rucker-Martin C,Hautefort A,Péchoux C,Bogaard HJ,Dorfmüller P,Remy S,Lecerf F,Planté S,Chat S,Fadel E,Houssaini A,Anegon I,Adnot S,Simonneau G,Humbert M,Cohen-Kaminsky S,Perros F
MA5-15827 was used in Western Blotting to demonstrate that rapamycin partially reverses the protein expression patterns of endothelial-to-mesenchymal transition (EndoMT), improves experimental pulmonary arterial hypertension, and decreases the migration of human pulmonary artery endothelial cells.
Tue Mar 17 00:00:00 UTC 2015
Endothelial-to-mesenchymal transition in pulmonary hypertension.
Circulation
Ranchoux B,Antigny F,Rucker-Martin C,Hautefort A,Péchoux C,Bogaard HJ,Dorfmüller P,Remy S,Lecerf F,Planté S,Chat S,Fadel E,Houssaini A,Anegon I,Adnot S,Simonneau G,Humbert M,Cohen-Kaminsky S,Perros F
MA5-15827 was used in Western Blotting to demonstrate that rapamycin partially reverses the protein expression patterns of endothelial-to-mesenchymal transition (EndoMT), improves experimental pulmonary arterial hypertension, and decreases the migration of human pulmonary artery endothelial cells.
Tue Mar 17 00:00:00 UTC 2015